Search
for
Sort by
Research 91–120 of 1000+
- Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Albendazole-induced anagen effluvium
- Review of Fluconazole Properties and Analytical Methods for Its Determination
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Metformin or thiazolidinedione therapy in PCOS?
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Red ginseng monograph
- Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Psychological and psychiatric characterization of various groups of drugs users
- Chromatographic Method for Simultaneous Quantification of Gemcitabine and Olaparib Recovered from Isolated Pancreatic Tissue
- Docking and Molecular Dynamics Identify Leads against 5 Alpha Reductase 2 for Benign Prostate Hyperplasia Treatment
- Development and Characterization of Dual-Loaded Niosomal Ion-Sensitive In Situ Gel for Ocular Delivery
- A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Improving selective androgen receptor modulator discovery and preclinical evaluation
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Drug repositioning using <i>in silico</i> compound profiling
- Ritlecitinib in severe alopecia areata: a profile of its use
- Liposome-based drug delivery systems for skin wound healing: a promising drug delivery strategy
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Nanocarrier Systems for Transdermal Drug Delivery
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Drug Repurposing Patent Applications July–September 2025